UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000049731
Receipt number R000056637
Scientific Title Validity of Oxygen Administration in Intravenous Sedation in Dentistry Using Oxygenation Reserve (ORi) as an Index
Date of disclosure of the study information 2022/12/08
Last modified on 2022/12/08 15:49:09

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Validity of Oxygen Administration in Intravenous Sedation in Dentistry Using Oxygenation Reserve (ORi) as an Index

Acronym

Validity of Oxygen Administration in Intravenous Sedation in Dentistry Using Oxygenation Reserve (ORi) as an Index

Scientific Title

Validity of Oxygen Administration in Intravenous Sedation in Dentistry Using Oxygenation Reserve (ORi) as an Index

Scientific Title:Acronym

Validity of Oxygen Administration in Intravenous Sedation in Dentistry Using Oxygenation Reserve (ORi) as an Index

Region

Japan


Condition

Condition

Dental disease

Classification by specialty

Dental medicine

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

During sedation, oxygen is administered at a rate of 3 L to 5 L/min to prevent pulse oximetry and drug-induced desaturation. Because the oral cavity is the operative field in dentistry, the use of a neosurgical cannula is commonly used for oxygen administration, which may result in inadequate oxygen administration or ineffective administration routes. In this study, we will evaluate the appropriate oxygen dosage and the appropriateness of oxygen administration during sedation in the dental field by applying ORi and SpO2 monitoring.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

ORi

Key secondary outcomes



Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients who have undergone surgical dental procedures at Showa University Dental Hospital and Showa University Northern Yokohama Hospital and are at least 20 years of age.
American Society of Anesthesiologists physical status1or2

Key exclusion criteria

Patients with contraindications to propofolor/and midazolam.
Patients deemed by the principal investigator and principal investigator to be appropriate for non-participation in the study

Target sample size

50


Research contact person

Name of lead principal investigator

1st name MEGURU
Middle name
Last name YAMADA

Organization

SHOWA University

Division name

Department of Perioperative Medicine, Division of Anesthesiology

Zip code

145-8515

Address

2-1-1,Kitasenzoku,Oota-ku,Tokyo,Japan

TEL

03-3787-1151

Email

meyamada@dent.showa-u.ac.jp


Public contact

Name of contact person

1st name Meguru
Middle name
Last name Yamada

Organization

SHOWA University

Division name

Department of Perioperative Medicine, Division of Anesthesiology

Zip code

145-8515

Address

2-1-1,Kitasenzoku,Oota-ku,Tokyo,Japan

TEL

03-3787-1151

Homepage URL


Email

meyamada@dent.showa-u.ac.jp


Sponsor or person

Institute

SHOWA University

Institute

Department

Personal name



Funding Source

Organization

SHOWA University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Showa University Research Ethics Review Board

Address

1-5-8,Hatanodai,Shinagawa-ku,Tokyo

Tel

03-3784-8129

Email

m-rinri@ofc.showa-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 12 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

50

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

No longer recruiting

Date of protocol fixation

2021 Year 12 Month 27 Day

Date of IRB

2022 Year 03 Month 02 Day

Anticipated trial start date

2022 Year 03 Month 03 Day

Last follow-up date

2022 Year 05 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

observational study


Management information

Registered date

2022 Year 12 Month 08 Day

Last modified on

2022 Year 12 Month 08 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000056637


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name